Jesús G. Berdeja
Jesús G. Berdeja publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, CAR-T cell therapy research and Protein Degradation and Inhibitors.
- World rank
- #323,913 of 7,710,434 ranked researchers
- Rank in United States
- #116,942 of 1,627,098
- Works
- 537
- Citations
- 20k
- Citations per work
- 36.6
What does Jesús G. Berdeja research?
Jesús G. Berdeja's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences32660.7%
- Medicine32660.7%
- Life Sciences14527.0%
- Everything else6612.3%
- 1Hematology31% of their works
- 2Molecular Biology21% of their works
- 3Oncology20% of their works
- 4Genetics6% of their works
- 5Immunology6% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
Which keywords describe Jesús G. Berdeja's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, CAR T Cells, Chimeric Antigen Receptor, BET Bromodomains, PROTACs, Prognostic Factors and Monoclonal Antibodies.
- Taxanes
- Therapeutic Antibodies
- Acute Myeloid Leukemia
- Immunogenicity
- Genomic Aberrations
- Monoclonal Antibodies
- PROTACs
- Chimeric Antigen Receptor
- International Myeloma Working Group
- Diagnosis Criteria
- CAR T Cells
- BET Bromodomains
- Prognostic Factors
- Chronic Lymphocytic Leukemia
- Biosimilars
- AML
- Fc Receptors
- Chemotherapy-Induced Peripheral Neuropathy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Diagnosis Criteria3131 topic
- International Myeloma Working Group3131 topic
- CAR T Cells1531 topic
- Chimeric Antigen Receptor1531 topic
- BET Bromodomains1341 topic
- PROTACs1341 topic
- Prognostic Factors1042 topics
- Monoclonal Antibodies802 topics
- Chronic Lymphocytic Leukemia641 topic
- Genomic Aberrations641 topic
- Biosimilars411 topic
- Immunogenicity411 topic
- AML401 topic
- Acute Myeloid Leukemia401 topic
- Fc Receptors391 topic
- Therapeutic Antibodies391 topic
- Chemotherapy-Induced Peripheral Neuropathy361 topic
- Taxanes361 topic
Where does Jesús G. Berdeja work?
Jesús G. Berdeja's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Jesús G. Berdeja have?
OpenAlex counts 537 works and 19,638 citations for Jesús G. Berdeja, an h-index of 61, ranking #323,913 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jesús G. Berdeja. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.